What drives the people of ICON Biotech? In this series of articles, we profile members of our team and learn how their life experiences influence their careers. Biotech demands deep scientific knowledge and resilience. The stories shared here exemplify these traits, demonstrating how challenges can transform into positive impact. Discover how personal experiences translate into fresh perspectives and unexpected insights for ICON Biotech customers.
Heidi Hoppe
When Heidi Hoppe began her career more than two decades ago, she didn’t plan on becoming the Senior Director of Project Delivery for Biotech at one of the world’s largest CROs. She hadn’t planned on being in the industry at all.
Mark Sorrentino
One would expect a driven and empathetic person at the helm of the industry’s leading pediatric clinical development centre, but Mark’s particular brand of tenacious empathy would undoubtedly surprise you.
Bojana Miorsavljevic
When companies seek support with rare disease patient advocacy, ICON Biotech’s Bojana Mirosavljevic brings hard won insights. As an embryologist and mother of a rare disease patient, she sees patient advocacy from the dual perspectives of science and caregiver.
In this section
-
Biotech
-
Behind Biotech: Stories of science and resilience
-
Early phase challenges for biotechs
-
Early phase development: Understanding key obstacles for biotechs in 2024
-
Emerging biotech funding
-
Externalised development for biotechs
-
Early engagement and regulatory considerations for biotech
-
De-risking clinical development of precision medicines in oncology
-
Methods and technologies advancing Alzheimer’s and Parkinson’s R&D
-
ICON survey report: CNS therapeutic development
-
Behind Biotech: Stories of science and resilience
- Government and Public Health
- Medical Device
- Pharmaceuticals